Get the Stockscreener App
1.6994
2.89%
-0.0506
Climb Bio Inc stock is traded at $1.6994, with a volume of 143.74K.
It is down -2.89% in the last 24 hours and up +34.87% over the past month.
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
See More
Previous Close:
$1.75
Open:
$1.75
24h Volume:
143.74K
Relative Volume:
0.42
Market Cap:
$114.87M
Revenue:
-
Net Income/Loss:
$-64.20M
P/E Ratio:
-0.7904
EPS:
-2.15
Net Cash Flow:
$57,000
1W Performance:
+21.39%
1M Performance:
+34.87%
6M Performance:
+1.15%
1Y Performance:
+0.00%
1-Day Range:
$1.65
$1.76
1-Week Range:
$1.36
$1.85
52-Week Range:
$1.05
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
Name
Climb Bio Inc
Sector
Industry
Phone
1-866-857-2596
Address
20 WILLIAM STREET, WELLESLEY HILLS
Compare CLYM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.6999 | 117.58M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.97 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.42 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.95 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.26 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.12 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-06-25 | Initiated | Oppenheimer | Outperform |
| May-22-25 | Initiated | BTIG Research | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
Climb Bio Inc Stock (CLYM) Latest News
64,914 Shares in Climb Bio, Inc. (NASDAQ:CLYM) Bought by Bank of New York Mellon Corp - Defense World
What makes Climb Bio Inc. stock price move sharplyTen-Year Sector Performance and Summary Analysis - Newser
Is a relief rally coming for Climb Bio Inc. holdersFree Capital Efficiency Optimized Stock Alerts - Newser
TD Asset Management Inc Buys Shares of 89,400 Climb Bio, Inc. (NASDAQ:CLYM) - Defense World
Will Climb Bio Inc. stock recover after recent dropFree Weekly Watchlist of High Movers - Newser
Using Python tools to backtest Climb Bio Inc. strategiesFree ROI Boosting Trade Opportunity Calendar - Newser
Signal strength of Achieve Life Sciences Inc. stock in tech scannersWeekly Signal Report with Trend Summary - Newser
Using fundamentals and technicals on Republic Bancorp Inc.Free Daily Chart Pattern Stock Forecast - Newser
Climb Bio Inc. stock daily chart insightsFree ROI Driven Equity Selection With Safety - Newser
Building trade automation scripts for Climb Bio Inc.Daily Market Movers Screener with Filters - Newser
Climb Bio Inc. Company Revenue and Profit Trends: A Deep DiveSwing Entry Risk Mitigation with Chart Analysis - Newser
Applying Elliott Wave Theory to Under Armour Inc.Oversold Reversal Picks with Buy Zone - Newser
How Resilient Is Aclaris Therapeutics Inc. Stock During Economic DownturnsDaily Trade Monitor with Pattern Alerts - Newser
How to escape a deep drawdown in Tectonic Financial Inc.Buy Candidate Summary Based on Fundamentals - Newser
Climb Bio Inc (CLYM) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Climb Bio (CLYM.O) Surges 17%: Technical Signal, Order-Flow, and Sector Clues Unveiled - AInvest
Climb Bio (CLYM.O) Surges 17%: A Deep-Dive Into the Technical and Market Forces Behind the Move - AInvest
Volume spikes in Climb Bio Inc. stock – what they meanChart Pattern Recognition for Profit Timing - Newser
What is the dividend policy of Climb Bio Inc. stockDynamic profit opportunities - Jammu Links News
Using RSI to spot recovery in Ontrak Inc.Weekly Gain Forecast with Momentum Indicators - Newser
Is UPSD stock reversal real or fakeBuy Strategy Review With Performance Summary - Newser
How does Climb Bio Inc. generate profit in a changing economyGet daily expert analysis on top stocks - Jammu Links News
Why Climb Bio Inc. stock attracts strong analyst attentionFree Weekly Hot Picks With Buy Confidence - Newser
What are the latest earnings results for Climb Bio Inc.Unstoppable investment returns - Jammu Links News
When is Climb Bio Inc. stock expected to show significant growthDouble-digit growth - Jammu Links News
What drives Climb Bio Inc. stock priceGame-changing capital returns - Jammu Links News
Kalyani Forge Limited (513509) Stock RalliesSuperior investment outcomes - Jammu Links News
Is it the right time to buy Climb Bio Inc. stockTrack stocks with high upside potential easily - Jammu Links News
Should I hold or sell Climb Bio Inc. stock in 2025Build a portfolio that grows with the market - Jammu Links News
Does GRI Bio Inc. stock perform well during market downturnsBreakneck growth rates - Jammu Links News
What is Tharimmune Inc. company’s growth strategyUnprecedented profits - Jammu Links News
Will Climb Bio Inc. price bounce be sustainableSafe and Scalable Return Strategy Blueprint - Newser
Oppenheimer Predicts Up to 590% Rally for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
How does Climb Bio Inc. compare to its industry peersAchieve breakthrough profits with smart strategies - Jammu Links News
Competitive Positioning of TECK: Is It Leading or LaggingFree Entry Zone Strategy for Consistent Profit - Newser
What institutional investors are buying Climb Bio Inc. stockMarket-beating performance - Jammu Links News
Climb Bio Inc. Stock Analysis and ForecastOutstanding risk-reward balance - Jammu Links News
What are the latest earnings results for Boundless Bio Inc.Stay ahead with advanced stock screening tools - Jammu Links News
How many analysts rate Climb Bio Inc. as a “Buy”Discover undervalued opportunities early - Jammu Links News
What are analysts’ price targets for Climb Bio Inc. in the next 12 monthsCapitalize on market trends with confidence - Jammu Links News
Does TELA Bio Inc. stock perform well during market downturnsOver 200% growth - Jammu Links News
How volatile is Climb Bio Inc. stock compared to the marketMaximize your portfolio’s earning potential - Jammu Links News
What are the latest earnings results for USAUMaximize your portfolio’s earning power - jammulinksnews.com
How strong is Passage Bio Inc. company’s balance sheetDiscover dynamic stocks ready to soar - Jammu Links News
What the charts say about MBOT todayFree Safe Entry Stock Watch Suggestions - Newser
Developing predictive dashboards with BITF dataShort Term Momentum Based Trading Strategy - Newser
How Climb Bio Inc. stock performs during market volatilitySwing Entry Insight With Forecast Accuracy - Newser
How to manage a losing position in Leidos Holdings Inc.Market Liquidity and Price Flow Analysis - Newser
Does Cipher Mining Inc. fit your quant trading modelTrend Reversal Watch with Entry Signals - Newser
Climb Bio Inc Stock (CLYM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Climb Bio Inc Stock (CLYM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | SVP, Finance & CAO |
Jun 20 '25 |
Sale |
1.24 |
1,242 |
1,540 |
18,888 |
| Pimblett Emily | SVP, Finance & CAO |
Mar 20 '25 |
Sale |
1.31 |
1,199 |
1,571 |
15,130 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Sep 20 '24 |
Sale |
8.18 |
1,191 |
9,741 |
7,564 |
0.36%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):